Effets paradoxaux des agents anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2007, Num 336, pp 11-12, issn 0761-5027, 2 p., SUPArticle

Immunogénicité des anti-TNFαSARAUX, A.La Lettre du rhumatologue. 2007, Num 336, pp 3-4, issn 0761-5027, 2 p., SUPArticle

A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclooxygenase-2 and tumour necrosis factor α inhibitorsYAZICI, Y; YAZICI, H.Annals of the rheumatic diseases. 2007, Vol 66, Num 1, pp 124-127, issn 0003-4967, 4 p.Article

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor α inhibitors in rheumatoid arthritisBOBBIO-PALLAVICINI, Francesca; CAPORALI, Roberto; ALPINI, Claudia et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 3, pp 302-307, issn 0003-4967, 6 p.Article

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapyROUX, C. H; BROCQ, O; BREUIL, V et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 4, pp 695-698, issn 1462-0324, 4 p.Article

Infections et anti-TNF : le bilan après huit ans d'utilisationMARIETTE, Xavier.Revue du rhumatisme (Ed. française). 2007, Vol 74, pp 5-10, issn 1169-8330, 6 p., HS2Article

L'efficacité des anti-TNF au cours de la polyarthrite rhumatoïde. Objectif rémission en 2007 ?SIBILIA, Jean.Revue du rhumatisme (Ed. française). 2007, Vol 74, pp 11-15, issn 1169-8330, 5 p., HS2Article

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor a antagonistsCURTIS, Jeffrey R; JUAN XI; PATKAR, Nivedita et al.Arthritis and rheumatism. 2007, Vol 56, Num 12, pp 4226-4227, issn 0004-3591, 2 p.Article

Que devient la réponse lymphocytaire T sous anti-TNF ? = What happens to T-lymphocyte response in patients treated with TNF antagonists?EMILIE, Dominique.Revue du rhumatisme (Ed. française). 2007, Vol 74, Num 10-11, pp 961-962, issn 1169-8330, 2 p.Conference Paper

Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitorHALL, Harald A; ZIMMERMANN, Bernard.Arthritis care and research. 2006, Vol 55, Num 6, pp 982-984, issn 0893-7524, 3 p.Article

Traitement anti-TNF en clinique courante. Efficacité sur trois ans chez des patients atteints de polyarthrite rhumatoïde = Anti tumour necrosis factor-alpha therapy in the ordinary clinical setting. Three-year effectiveness in patients with rheumatoid arthritisKVALVIK, Anne Grimstvedt; LEFSAKER, Liv; DYVIK, Siri et al.Revue du rhumatisme (Ed. française). 2007, Vol 74, Num 12, pp 1276-1282, issn 1169-8330, 7 p.Article

Anti-tumor necrosis factor α therapy and the risk of serious bacterial infections in Elderly patients with rheumatoid arthritisSCHNEEWEISS, Sebastian; SETOGUCHI, Soko; WEINBLATT, Michael E et al.Arthritis and rheumatism. 2007, Vol 56, Num 6, pp 1754-1764, issn 0004-3591, 11 p.Article

Insulin resistance in patients with rheumatoid arthritis : effect of anti-TNFα therapyROSENVINGE, A; KROGH-MADSEN, R; BASLUND, B et al.Scandinavian journal of rheumatology. 2007, Vol 36, Num 2, pp 91-96, issn 0300-9742, 6 p.Article

Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-α inhibitors in adults with rheumatoid arthritisGREENWOOD, M. C; RATHI, J; HAKIM, A. J et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 7, pp 1165-1167, issn 1462-0324, 3 p.Article

What effects might anti-TNFα treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFα in cardiovascular pathophysiologyDIXON, W. G; SYMMONS, D. P. M.Annals of the rheumatic diseases. 2007, Vol 66, Num 9, pp 1132-1136, issn 0003-4967, 5 p.Article

Optic neuritis occurring with anti-tumour necrosis factor α therapySIMSEK, Ismail; ERDEM, Hakan; PAY, Salih et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 9, pp 1255-1258, issn 0003-4967, 4 p.Article

Switching tumour necrosis factor α antagonists in patients with ankylosing spondylitis and psoriatic arthritis : an observational study over a 5-year periodCONTI, Fabrizio; CECCARELLI, Fulvia; MAROCCHI, Elisa et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 10, pp 1393-1397, issn 0003-4967, 5 p.Article

Utilisation de l'infliximab dans le traitement du rhumatisme psoriasique au cours de l'infection par le virus de l'immunodéficience humaine (VIH) = Use of infliximab to treat psoriatic arthritis in HIV-positive patientsSELLAM, Jérémie; BOUVARD, Béatrice; BERENBAUM, Francis et al.Revue du rhumatisme (Ed. française). 2007, Vol 74, Num 3, pp 297-300, issn 1169-8330, 4 p.Article

Requirement of Methotrexate in Combination with Anti-Tumor Necrosis Factor-α Therapy for Adequate Suppression of Osteoclastogenesis in Rheumatoid ArthritisMATSUNO, Hiroaki; YOSHIDA, Kaoru; OCHIAI, Akira et al.Journal of rheumatology. 2007, Vol 34, Num 12, pp 2326-2333, issn 0315-162X, 8 p.Article

Anti-tumour necrosis factor α therapy in patients with impaired renal functionHUEBER, Axel J; TUNC, Andac; SCHETT, Georg et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 7, pp 981-982, issn 0003-4967, 2 p.Article

Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practiceBOMBARDIERI, S; RUIZ, A. A; FARDELLONE, P et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 7, pp 1191-1199, issn 1462-0324, 9 p.Article

Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritisDEL PORTO, F; LAGANA, B; LAI, S et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 7, pp 1111-1115, issn 1462-0324, 5 p.Article

Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists : Evidence for improved adrenal functionERNESTAM, Sofia; HAFSTRÖM, Ingiäld; WERNER, Sigbritt et al.Journal of rheumatology. 2007, Vol 34, Num 7, pp 1451-1458, issn 0315-162X, 8 p.Article

Long-term treatment with methotrexate or tumor necrosis factor α inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritisBALANDRAUD, Nathalie; GUIS, Sandrine; MEYNARD, Jean Baptiste et al.Arthritis care and research. 2007, Vol 57, Num 5, pp 762-767, issn 0893-7524, 6 p.Article

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agentsBRAUN, J; BARALIAKOS, X; LISTING, J et al.Arthritis care and research. 2007, Vol 57, Num 4, pp 639-647, issn 0893-7524, 9 p.Article